Organization
Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary
2 abstracts
Abstract
A phase 3, open-label, randomized study to evaluate the efficacy and safety of single-agent belantamab mafodotin (belamaf) compared to pomalidomide plus low-dose dexamethasone (Pd) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): DREAMM‑3.Org: Clinica São Germano, São Paulo, Brazil, General Hospital Evangelismos, Athens, Greece, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary, Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil, GSK, Upper Providence, PA,
Abstract
AORTITIS PRESENTING AS FEVER OF UNKNOWN ORIGIN – FDG PET FOR DIAGNOSIS AND FOLLOW UPOrg: Department of Internal Medicine E, Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, The B. Shine Department of Rheumatology, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary, Rambam Medical Center,